Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.

ABSTRACT:

Background

Coronavirus disease 2019 (COVID-19) is an infectious disease characterized by cough, fever, and fatigue and 20% of cases will develop into severe conditions resulting from acute lung injury with the manifestation of the acute respiratory distress syndrome (ARDS) that accounts for more than 50% of mortality. Currently, it has been reported that some comorbidities are linked with an increased rate of severity and mortality among COVID-19 patients. To assess the role of comorbidity in COVID-19 progression, we performed a systematic review with a meta-analysis on the relationship of COVID-19 severity with 8 different underlying diseases.

Methods

PubMed, Web of Science, and CNKI were searched for articles investigating the prevalence of comorbidities in severe and non-

SUBMITTER: Yin T 

PROVIDER: S-EPMC7897883 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature